Myriad Genetics Files 8-K on Financials
Ticker: MYGN · Form: 8-K · Filed: Aug 5, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, sec-filing
Related Tickers: MYGN
TL;DR
MYGN filed an 8-K on Aug 5th detailing financial results.
AI Summary
Myriad Genetics, Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. The report was filed with the SEC under the 1934 Act.
Why It Matters
This 8-K filing provides crucial updates on Myriad Genetics' financial health and operational results, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant risks.
Key Players & Entities
- MYRIAD GENETICS INC (company) — Registrant
- 0000899923-25-000084 (filing_id) — Accession Number
- August 5, 2025 (date) — Date of Report
- 322 North 2200 West Salt Lake City, Utah 84116 (address) — Principal Executive Offices
- 801-584-3600 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on August 5, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 322 North 2200 West, Salt Lake City, Utah 84116.
Under which SEC Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Myriad Genetics, Inc. is 87-0494517.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding MYRIAD GENETICS INC (MYGN).